- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
<b>Efficacy of a Supplement Containing Freeze-dried Earthworm Powder for Atherosclerosis</b>
-
- ANAMIZU Soichiro
- Tokyo Total Life Clinic
-
- NAGAYA Naoki
- Tokyo Total Life Clinic
-
- TO Junichiro
- Tokyo Total Life Clinic
-
- MABUCHI Shigeki
- Tokyo Total Life Clinic
Bibliographic Information
- Other Title
-
- <b>凍結乾燥ミミズエキス含有サプリメントによる動脈硬化改善効果の検討</b>
- 凍結乾燥ミミズエキス含有サプリメントによる動脈硬化改善効果の検討
- トウケツ カンソウ ミミズエキス ガンユウ サプリメント ニ ヨル ドウミャク コウカ カイゼン コウカ ノ ケントウ
Search this article
Description
We studied the effects of a supplement containing freeze-dried earthworm powder : “Protein Related compound Derived from Redworm (PR-DR)” for atherosclerosis in 19 patients (10 females, average age : 61.5 ± 6.9), whose vascular ages were estimated to be older than their actual ages based on the index of atherosclerosis ; Intima-Media Thickness (IMT) by carotid ultrasonography and Cardio-Ankle Vascular Index (CAVI). After we obtained informed consent, they took daily dose of 6 PR-DR capsules for 6 months. Each capsule contains 40 mg of powdered extract of Lumbricus rubellus, which is known to contain fibrin-degrading an enzyme and to increase the effect of t-PA.<br>Before and 6 months after intake, we found significant decrease in 3 indicators of atherosclerosis. The scores of difference between 2 time points (6 month-pre) were IMT-Cmax : -0.15 ± 0.16 mm, maxIMT : -0.22 ± 0.17 mm, plaque score : -1.57 ± 1.12 (all p < 0.01 by Wilcoxon signed-rank test). As statins and EPA also decrease atherosclerosis, we excluded 6 patients who were taking these medications. Even in the remaining 13 patients (7 females, average age : 61.2 ± 7.9), 3 indicators were still significantly lower (IMT-Cmax : -0.07 ± 0.07 mm, maxIMT : -0.19 ± 0.17 mm, plaque score : -1.39 ± 1.04 ; all p < 0.01) after 6 months of intake. Thus, the results showed that PR-DR has anti-atherosclerosis effect and can be used clinically for the prevention of atherosclerosis and diseases associated with it.
Journal
-
- Kampo Medicine
-
Kampo Medicine 66 (4), 275-281, 2015
The Japan Society for Oriental Medicine
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679888523008
-
- NII Article ID
- 130005125810
-
- NII Book ID
- AN00015774
-
- ISSN
- 1882756X
- 02874857
-
- NDL BIB ID
- 026942171
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed